Galapagos | GLPG - Operating Profit

Stock Price
29.56
Daily Change
1.16 4.08%
Monthly
2.14%
Yearly
17.30%
Q1 Forecast
27.85

Galapagos reported EUR-41.67M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
argenx SE USD 349.97M 146.13M Sep/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Biogen USD 659.6M 192.2M Sep/2025
Genmab DKK 360M 172M Jun/2025
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 2.57M Sep/2025
Hikma Pharmaceutical USD 187M 95M Jun/2025
Incyte USD 383.88M 47.43M Dec/2025
Merck EUR 1.21B 180M Sep/2025
Neurocrine Biosciences USD 227.9M 11.4M Dec/2025
Novartis USD 4.5B 363M Sep/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
UCB EUR 1B 678M Dec/2024
Vertex Pharmaceuticals USD 1.26B 24.5M Dec/2025